Skip to main content
Journal of Medicine and Life logoLink to Journal of Medicine and Life
. 2023 Jan;16(1):35–41. doi: 10.25122/jml-2022-0187

Outcomes of laser-induced thermotherapy for thyroid nodules at the West Vascular Center, Ukraine

Michael Ivanovich Sheremet 1,2,*, Oleksandr Volodimirovich Lazaruk 2,3, Oleksandr Viktorovich Shidlovskyi 4, Viktor Oleksandrovich Shidlovskyi 4, Volodimir Vasilyevich Savin 2, Yuriy Vasilyevich Olinik 2, Oksana Yuriivna Olinik 5, Tetyana Yuriivna Lazaruk 2,5
PMCID: PMC9979181  PMID: 36873136

Abstract

Thyroid nodules are common, occurring in 50–60% of healthy patients. Currently, there are no effective conservative treatment options for nodular goiter, and surgery can have limitations and potential complications. The purpose of this study was to evaluate the efficacy, tolerability, and long-term results of using sclerotherapy and laser-induced interstitial thermotherapy (LITT) to treat benign thyroid nodules. A retrospective analysis was conducted on 456 patients with benign nodular goiter who received LITT. The volume of the nodular goiter was measured at 1, 3, 6, and 12 months post-treatment, and a repeated fine needle aspiration (FNA) with the cytological examination was performed to verify the structure of the nodular goiter in the long term. The results showed that LITT was an effective method for treating nodular mass (nodules), as evidenced by a decrease in the volume of NG by 51–85% after 6–12 months. FNA results 2–3 years after LITT showed no thyrocytes, only connective tissue, indicating the efficacy of LITT for benign thyroid nodules. LITT is highly effective in most cases, often resulting in the disappearance or significant decrease in nodular formations.

Keywords: laser-induced thermotherapy, sclerotherapy, nodular goiter

ABBREVIATIONS: LITT – laser-induced thermotherapy, FNA – fine needle aspiration puncture biopsy, NG – nodular goiter, TSH – thyroid-stimulating hormone TG – thyroid gland, TgAb – thyroglobulin antibody, TPOAb – thyroid peroxidase antibody

INTRODUCTION

Thyroid nodules are a common occurrence in clinical practice, with a prevalence ranging from 3–7% based on physical examination and up to 76% based on thyroid sonography [17]. Although most thyroid nodules, according to fine-needle aspiration puncture biopsy, are benign, do not cause compression complaints, and do not require specific treatment, individual nodules can increase in size, causing symptoms or neck deformation in the patient, and can lead to excessive production of thyroid hormones [811]. Therefore, some patients with benign thyroid nodules require corrective treatment.

According to recent research, an alternative to surgical treatment of benign thyroid nodules is laser-induced thermotherapy (LITT) of thyroid nodules under ultrasound control [1215]. LITT of thyroid nodules was developed and introduced in 1998 to treat solid thyroid nodules [1416].

The LITT is a minimally invasive treatment method based on the combined action of light and temperature at the end of the light pipe that is brought into the tumor itself (node). A temperature of 41–46 degrees is applied, affecting the protein structures of the cell without destroying it as a whole, but further cell division of the nodule parenchyma becomes impossible [1720]. LITT is widely used in countries such as America, Western Europe, Asia, and Japan [2125].

According to current guidelines for treating thyroid nodules, ultrasound-guided laser-induced thermotherapy of thyroid nodules can be used to treat solid and cystic nodules. The thyroid gland, gradually increasing in size, causes symptoms of thyrotoxicosis or creates cosmetic issues [2227].

The objective of this study was to evaluate the efficiency, tolerability, and long-term results of the use of sclerotherapy and LITT for the treatment of benign thyroid nodules.

MATERIAL AND METHODS

The Lahta Milon® diode laser 1060/90 model was used. The LITT was conducted according to the following parameters: wavelength 1060 NG, continuous mode, and radiation power ranging from 2.5 to 3.2 W. A 400 µm quartz laser fiber with a torsional end was used, which was inserted into the needle lumen of a 5 mm fiber coming out of the needle. After LITT, changes in the node and perinodal tissue were determined on the second day, in 2 weeks, in 1, 3, 6, 9, and 12 months after the manipulation. Changes in the volume of nodes and their structure were studied using the TOSHIBA Aplio XG A ultrasonic device. Thyroid function was determined one month after the LITT.

The inclusion criteria for this retrospective study were as follows:

  • Solid nodules from 0.5 to 45 cm3 (fluid component ≤10%); if the fluid component percentage was higher, fluid component evacuation and chemical sclerotherapy with 96% ethanol were performed;

  • Diagnosis of benignity by 3–4 fine needle aspiration biopsies – Bethesda Category II, 2017;

  • Normal levels of TSH (thyroid-stimulating hormone), FT4 (free thyroxine), TgAb (thyroglobulin antibodies), TPOAb (thyroid peroxidase antibodies), and calcitonin

  • The presence of local compression symptoms;

  • Refusal of an open operation or the availability of contraindications to it.

Informed consent was obtained in writing from all patients meeting the inclusion criteria. From December 2019 to June 2022, 456 patients were treated. The distribution of patients by age, gender, and type of nodes is presented in Table 1.

Table 1.

Patient characteristics.

Number 456
Age 18–78 (56)
Gender – female/male 399/57
Neoplasm type:
1. Adenomatous nodes 56
2. Colloid goiter 237
3. Nodular goiter with cystic degeneration 163

RESULTS

Patients were positioned lying on their backs with their heads thrown back and a pad under the shoulder blades. The laser light guide was inserted from the side of the isthmus into the lateral part of the node. The input of the light guide was visualized under ultrasound navigation, while the zone of the triangle, including the reverse laryngeal nerve and/or esophagus, accounted for the minimum amount of thermal energy. To avoid damage to adjacent organs, we maintained a distance of at least 15 mm from the fiber tip to the distal edge of the nodule and a 10 mm distance from the surrounding structure and the edge of the nodule capsule. Local anesthesia with 2% lidocaine hydrochloride solution was applied at the site of the light guide insertion, while sedation was not used since we used the manifestation of a minor pain symptom or burning sensation as a guideline for the final cessation or reduction of energy delivery.

A positive result was defined as a reduction of ≥50% in 1 year after treatment. Changes in the node, perinodal tissue, and gland function after LITT were determined on the second day, 2 weeks later, 1, 3, 6, 9, and 12 months after the manipulation.

On the second day after the LITT, the volume of nodes increased by 20–35% compared with the initial data. The percentage of their growth depended on echogenicity. Hyperechogenic nodes increased by 20–25%, isoechoic – by 25–30%, and hypoechoic – by 25–35%. An increase in the volume of nodes is a consequence of aseptic inflammation and swelling of the tissue inside the node.

Table 2 shows the distribution of significant reductions in nodule size following LITT. This table shows that among the nodes of up to 1 cm3 after the LITT, the entire part decreased by more than 75%, 48 (37.4%) nodes decreased by more than 75%, and 84 (63.6%) nodes disappeared completely. Among the nodules with 1–2 cm3 volume, all nodules decreased by more than 75%, of which 151 (75%) or more and 62 (29.1%) – scar tissue with zero volume remained. At the same time, among nodular formations from 2 to 4 cm3, there was not a single node that disappeared completely. However, in 60 (89.5%) patients, the node volume decreased by more than 75%, and in 7 (10.5%) – from 50% to 75%. When analyzing the reduction of nodes with a volume from 8 to 45 cm3, it should be emphasized that all formations probably decreased after sclerotherapy with ethanol and after using the LITT in more than 4 projections. This technology made it possible to fully heat the entire tissue of the node with a laser (Figure 1).

Table 2.

Relative decrease in the volume of thyroid nodules 1 year after LITT.

Decrease after LITT to 1 cm3 n=132 from 1 to 2 cm3 n=213 from 2 to 4 cm3 n=67 from 4 to 8 cm3 n=25 from 8 to 45 cm3 n=19
Completely disappeared 84/100% 62/100% - - -
75% and more 48/74.6% 151/70.9% 60/89.5% 13/52% 7/37%
50–75% - - 7/10.5% 6/24% 5/26%
40–50% - - - 6/24% 5/26%
Less than 40% - - - - 4/11%

Figure 1.

Figure 1

Laser fiber in the center of the node.

When examining patients after 1 year, the positive therapeutic effect was maintained. Thus, most nodes decreased by more than 40–50% (Table 2).

We analyzed the LITT efficiency depending on the number of projections and the duration of laser exposure to the node tissue. By the number of projections of laser exposure, we understand not just the movement of the laser light guide but the number of punctures of the puncture needle with re-insertion of the light guide after removing carbon deposits from it. At the same time, direct proportional dependence between the number of projections and a decrease in the volume of thyroid gland nodes was established.

In 15 out of 44 (34.1%) patients with "large nodes" from 8 to 45 cm3 after the first LITT session, the efficiency was observed in 25 to 42%. Subsequently, a second LITT session was performed, and in 6 (13.6%) patients, two LITT sessions were performed. As a result of the sessions, the volume of nodes decreased by more than 55%, while the compression syndrome significantly decreased and the need for the surgery vanished (Figure 2).

Figure 2.

Figure 2

Figure 2

Node volume before and 12 months after LITT.

Transient sub-febrile fever and local pain were reported in some patients, but the absolute number and percentage of patients reporting these side effects were small [sub-febrile fever: 3 patients (0.6%); pain: 2 patients (0.2%)].

According to repeat fine-needle aspiration biopsies (FNA) taken 2–3 years after LITT, the microscopic changes that occurred in the treated node were determined. The results showed that the ablation zone was surrounded by a peripheral rim of dense fibrous tissue. The area of destruction was characterized by the presence of amorphous material, macrophages, multinucleated giant cells, and lymphocytes, but no thyroid cells. Viable tissue was visible at the periphery, separated from the ablation zone by fibrous tissue.

The ultrasound characteristics of the node were represented by cicatricial, fibrous changes with hyperechoic areas that give a positive echo + shadow and hypoechoic areas of irregular shape as a result of proliferative and regenerative processes in the node.

DISCUSSION

Recent studies have proposed a unified terminology for laser-induced thermotherapy (LITT) of thyroid nodules using ultrasound guidance, in which nodules are classified as "small" if they have a volume of ≤10 cm3, "medium" if the volume is 11–30 cm3, and "large" if the volume >30 cm3 [28]. In our study group of 15 patients, the average size of the thyroid nodules was 38 cm3 with a range of 20–45 cm3, which classifies them as "large" according to recent proposals for the classification of LITT under sonographic guidance. These large nodules required a significant ablation volume for treatment.

Another group of researchers believes that during LITT, an increase in the photocoagulation volume in the transverse direction to the direction of needle insertion can be achieved by simultaneous illumination of more than one optical fiber located at a distance of 10–15 mm [28]. In addition, according to their data, an increase in the volume of ablation in the direction of needle insertion can be achieved by a maneuver of retraction and re-entry of the optical fiber in more than 6–8 projections. Using these approaches in combination with repeated LITT sessions has given experts very good technical results in reducing large nodules by 75% after 1 year. The effect of the treatment was long-lasting; the long-term effect lasted from 2 to 3 years after the initial treatment. The research showed that to obtain good results, an energy dose exceeding 500 J/cm3 of nodal tissue is required [29, 30]. In this series of patients, the average amount of energy delivered to the nodes was 461 J/cm3 of tissue. However, for very bulky nodules, it was necessary to add slightly less energy per 1 cm3; otherwise, it would lead to significant burns, and the treatment duration would be long enough, which is not acceptable for the treatment of such patients.

In our treatment series, patients tolerated laser ablation well and experienced minimal complications. Some patients had temporary fever and pain, but the number of patients affected was small (0.6% for fever and 0.2% for pain). These percentages align with findings from previous studies [31]. However, there is limited data from randomized controlled trials comparing laser ablation to other ultrasound-guided techniques.

One study that compared LITT to radiofrequency ablation, another minimally invasive treatment for thyroid nodules, was conducted on 58 patients with solid thyroid tumors. The study found that while radiofrequency ablation resulted in a greater reduction in nodule mass 12 months after treatment, both LITT and radiofrequency ablation had similar technical success rates and statistically significant improvements in compression symptoms and symptom scores [27]. Additionally, a retrospective analysis of 320 thyroid nodules in 320 predisposed patients compared laser ablation to microwave ablation. The study found that for nodules larger than 13 mL, the results of laser interstitial thermotherapy at 6 months and later were stronger than those obtained with microwave ablation, while overall group characteristics were comparable between RF and LITT [29].

R. Valcavi [16] and C. M. Pacella [32] observed hematoma in 2% of patients in the postoperative period, which was asymptomatic and was detected only by ultrasound in the form of a hypoechoic layer around the thyroid gland. No surgical intervention was required. The hematoma was resolved by the end of the third week. Irritation of the vagus nerve in the form of bradycardia was observed in 2%. Another 2% of patients complained of coughing during the procedure. 2% of patients complained of dysphonia. Laryngoscopy showed limited mobility of the vocal fold. However, after 2 months, the function of the vocal folds resumed. Rare side effects include skin burn (0.3%) and stridor (0.3%). Thyroid gland dysfunction was observed in 3% of patients (1 patient had hyperthyroidism, 1 – had hypothyroidism) [30].

Summing up the data obtained, the main advantages of the LITT over surgery should be noted: 1) it is a minimally invasive technology that has the same clinical results as surgery; 2) the LITT can be performed under local anesthesia and on the outpatient basis; 3) intra- and postoperative complications after the LITT are extremely rare and easily acquired; 4) the dynamic LITT technique allows overcoming the preliminary limiting factors of the technique, such as large node sizes, multinodular formations. Finally, the LITT is possible in most cases in patients with benign thyroid nodules.

CONCLUSION

The technique of laser-induced interstitial thermotherapy of benign thyroid nodules is highly effective since it leads either to the disappearance or to a significant decrease in nodular formations in the vast majority of cases.

The greatest efficiency of this technique is manifested in the treatment of small nodular formations – up to 10 cm3. However, nodes of this size are most common and, with a significant increase in the future, can have an adverse effect on the quality of life associated with their progressive growth and, as a result, the occurrence of a compression syndrome, which may require surgical treatment.

Also, the laser-induced interstitial thermotherapy saves the parenchyma of the gland and avoids the development of hypothyroidism and the LITT technique of colloid nodes with cystic transformation is safe and effective and based on it, we can recommend this technique for wide use in medical practice.

ACKNOWLEDGEMENTS

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

The study was conducted according to the ethical principles of the Helsinki Declaration, GCP (Good Clinical Practice), and Law of Ukraine regarding medications approved by the Commission of Ethics from the West Vascular Center (Minutes No. 7 of June 28, 2022).

Consent to participate

Written informed consent was obtained for all participants in the study.

Authorship

MIS contributed to work concept and design, data collection and analysis, writing the article, critical review, and final approval. OVL contributed to work concept and design, critical review, and final article approval. OVS contributed to data collection and analysis, writing the article, and critical review. VOS and VVS contributed to the work concept and design, data collection and analysis, writing the article, critical review, and final approval. MIS contributed to data collection and analysis, writing the article. YVO, OYO and TYL contributed to data collection and analysis, writing the article.

References

  • 1.Gharib H, Papini E, Garber JR, Duick DS, et al. American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Associazione Medici Endocrinologi Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules--2016 Update. Endocr Pract. 2016 May;22(5):622–39. doi: 10.4158/EP161208.G. [DOI] [PubMed] [Google Scholar]
  • 2.Shidlovskiy V, Shidlovskiy A, Karel O. Effects of percutaneous laser abla-tion treatment in benign solitary thyroid. The Ukrainian Journal of Surgery. 2011;2(11):120–125. [Google Scholar]
  • 3.Papini E, Pacella CM, Solbiati LA, Achille G, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36(1):376–382. doi: 10.1080/02656736.2019.1575482. [DOI] [PubMed] [Google Scholar]
  • 4.Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. Eur Thyroid J. 2020 Jul;9(4):172–185. doi: 10.1159/000508484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, Pacella S, Papini E. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000 Dec;217(3):673–7. doi: 10.1148/radiology.217.3.r00dc09673. [DOI] [PubMed] [Google Scholar]
  • 6.Pacella CM, Bizzarri G, Spiezia S, Bianchini A, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004 Jul;232(1):272–80. doi: 10.1148/radiol.2321021368. [DOI] [PubMed] [Google Scholar]
  • 7.Papini E, Guglielmi R, Persichetti A, Pacella CM. Benign thyroid nodule laser ablation. In: Pacella CM, Jiang T, Mauri G, editors. Image-guided laser ablation. Cham, Switzerland: Springer Nature Switzerland AG; 2020. pp. 61–73. [Google Scholar]
  • 8.Pacella CM, Mauri G, Achille G, Barbaro D, et al. Outcomes and Risk Factors for Complications of Laser Ablation for Thyroid Nodules: A Multicenter Study on 1531 Patients. J Clin Endocrinol Metab. 2015 Oct;100(10):3903–10. doi: 10.1210/jc.2015-1964. [DOI] [PubMed] [Google Scholar]
  • 9.Gambelunghe G, Fatone C, Ranchelli A, Fanelli C, et al. A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. J Endocrinol Invest. 2006 Oct;29(9):RC23–6. doi: 10.1007/BF03347368. [DOI] [PubMed] [Google Scholar]
  • 10.Papini E, Rago T, Gambelunghe G, Valcavi R, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014 Oct;99(10):3653–9. doi: 10.1210/jc.2014-1826. [DOI] [PubMed] [Google Scholar]
  • 11.Døssing H, Bennedbaek FN, Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007 Jul;157(1):95–100. doi: 10.1530/EJE-07-0094. [DOI] [PubMed] [Google Scholar]
  • 12.Papini E, Guglielmi R, Bizzarri G, Graziano F, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007 Mar;17(3):229–35. doi: 10.1089/thy.2006.0204. [DOI] [PubMed] [Google Scholar]
  • 13.Gambelunghe G, Bini V, Monacelli M, Avenia N, et al. The administration of anesthetic in the thyroid pericapsular region increases the possibility of side effects during percutaneous laser photocoagulation of thyroid nodules. Lasers Surg Med. 2013 Jan;45(1):34–7. doi: 10.1002/lsm.22110. [DOI] [PubMed] [Google Scholar]
  • 14.Gambelunghe G, Stefanetti E, Avenia N, De Feo P. Percutaneous Ultrasound-Guided Laser Ablation of Benign Thyroid Nodules: Results of 10-Year Follow-Up in 171 Patients. J Endocr Soc. 2021 May 5;5(7):bvab081. doi: 10.1210/jendso/bvab081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gambelunghe G, Stefanetti E, Colella R, Monacelli M, et al. A single session of laser ablation for toxic thyroid nodules: three-year follow-up results. Int J Hyperthermia. 2018 Aug;34(5):631–635. doi: 10.1080/02656736.2018.1437931. [DOI] [PubMed] [Google Scholar]
  • 16.Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010 Nov;20(11):1253–61. doi: 10.1089/thy.2010.0189. [DOI] [PubMed] [Google Scholar]
  • 17.Ahmed M, Solbiati L, Brace CL, Breen DJ, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–1705.e4. doi: 10.1016/j.jvir.2014.08.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199–202. doi: 10.1097/01.rvi.0000094584.83406.3e. [DOI] [PubMed] [Google Scholar]
  • 19.Na DG, Lee JH, Jung SL, Kim JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012 Mar-Apr;13(2):117–25. doi: 10.3348/kjr.2012.13.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mauri G, Pacella CM, Papini E, Solbiati L, et al. Image-Guided Thyroid Ablation: Proposal for Standardization of Terminology and Reporting Criteria. Thyroid. 2019 May;29(5):611–618. doi: 10.1089/thy.2018.0604. [DOI] [PubMed] [Google Scholar]
  • 21.Heisterkamp J, Van Hillegersberg R, Sinofsky E, Ijzermans JNM. Interstitial laser photocoagulation with four cylindrical diffusing fibre tips: Importance of mutual fibre distance. Lasers Med Sci. 1999;14(3):216–220. doi: 10.1007/s101030050087. [DOI] [Google Scholar]
  • 22.Gambelunghe G, Ristagno S, Stefanetti E, Avenia N, De Feo P. Ultrasound-guided laser ablation of very large benign thyroid nodules: 4-year, retrospective follow-up in 24 patients. Int J Hyperthermia. 2022;39(1):217–221. doi: 10.1080/02656736.2022.2025923. [DOI] [PubMed] [Google Scholar]
  • 23.Gambelunghe G, Fede R, Bini V, Monacelli M, et al. Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from a three-year pilot study. Surg Innov. 2013 Aug;20(4):345–50. doi: 10.1177/1553350612459276. [DOI] [PubMed] [Google Scholar]
  • 24.de Freitas RMC, Miazaki AP, Tsunemi MH, de Araujo Filho VJF, et al. Laser Ablation of Benign Thyroid Nodules: A Prospective Pilot Study With a Preliminary Analysis of the Employed Energy. Lasers Surg Med. 2020 Apr;52(4):323–332. doi: 10.1002/lsm.23144. [DOI] [PubMed] [Google Scholar]
  • 25.Gambelunghe G, Bini V, Stefanetti E, Colella R, et al. Thyroid nodule morphology affects the efficacy of ultrasound-guided interstitial laser ablation: a nested case-control study. Int J Hyperthermia. 2014 Nov;30(7):486–9. doi: 10.3109/02656736.2014.963701. [DOI] [PubMed] [Google Scholar]
  • 26.Negro R, Greco G, Deandrea M, Rucco M, Trimboli P. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study. Korean J Radiol. 2020 Jun;21(6):764–772. doi: 10.3348/kjr.2019.0798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cesareo R, Manfrini S, Pasqualini V, Ambrogi C, et al. Laser Ablation versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study) J Clin Endocrinol Metab. 2021 May 13;106(6):1692–1701. doi: 10.1210/clinem/dgab102. [DOI] [PubMed] [Google Scholar]
  • 28.Shi YF, Zhou P, Zhao YF, Liu WG, et al. Microwave Ablation Compared With Laser Ablation for Treating Benign Thyroid Nodules in a Propensity-Score Matching Study. Front Endocrinol (Lausanne) 2019 Dec 13;10:874. doi: 10.3389/fendo.2019.00874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Monpeyssen H, Ben Hamou A, Hegedüs L, Ghanassia É, et al. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: a 3-year retrospective multicenter follow-up study. Int J Hyperthermia. 2020;37(1):1301–1309. doi: 10.1080/02656736.2020. [DOI] [PubMed] [Google Scholar]
  • 30.Bernardi S, Giudici F, Cesareo R, Antonelli G, et al. Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group. Thyroid. 2020 Dec;30(12):1759–1770. doi: 10.1089/thy.2020.0202. [DOI] [PubMed] [Google Scholar]
  • 31.Gharib H, Papini E, Paschke R, Duick DS, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations Task Force on Thyroid Nodules. J Endocrinol Invest. 2010;33(5 Suppl):51–6. [PubMed] [Google Scholar]
  • 32.Cesareo R, Pacella CM, Pasqualini V, Campagna G, et al. Laser Ablation versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial) Thyroid. 2020 Jun;30(6):847–856. doi: 10.1089/thy.2019.0660. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medicine and Life are provided here courtesy of SC Jurnalul pentru Medicina si Viata SRL

RESOURCES